Injective (INJ) Recovery Potential: Key Levels Point Toward $11.33 Upside

• Injective (INJ) has been moving lower steadily since mid-October.
• Immediate support is around $5.00, while a stronger floor lies near $2.60.
• Potential upside targets are $6.99, $8.17, $8.90, and $11.33.
• Chainlink integration boosts Injective’s speed and developer appeal.

Injective (INJ) has been in a clear downtrend since mid-October, showing a pattern of lower highs and lower lows. Recently, the price dropped below $6.02, turning that level into resistance. The short-term EMA 13 is below EMA 50 and EMA 200, confirming bearish momentum. Sellers remain in control, but any bounce could test upward targets at $6.99, $8.17, and higher levels.

The nearest support is $5.00, a key psychological level near recent lows. A breakdown could push the price toward $2.60, the bottom of the descending channel. Immediate resistance stands at $6.99 (0.382 Fib), while higher upward targets include $8.17 (0.618 Fib), $8.90 (1 Fib), $10.24 (1.36 Fib), and $11.33 (1.618 Fib). Each level may slow a recovery attempt.

The downtrend remains, which is likely to form a Descending Channel or Flag pattern. Previous efforts to form a bullish pattern failed, so it appears that selling is in control. The price remains below EMA 13, EMA 50, and EMA 200. For now, the nearest support level is $5.00, but long-term support is at $2.60. Key support levels are $6.99, $8.17, $8.90, and $11.33.

Also Read: Injective Partners with Chainlink to Boost Low-Latency Financial Data

INJ Technical Indicators Show Weakness

With the RSI sitting near 30, the token looks close to being oversold, which often hints that the heavy selling might be easing up. Even so, the indicator is still sliding downward, showing the trend hasn’t shifted yet. Price movement agrees, with steady lower highs and lows keeping the overall decline intact.

The MACD remains below zero, pointing to continued bearish momentum, although the fading histogram bars show the pressure isn’t as intense as before. A real shift won’t be clear until the MACD moves above the signal line. Watching for the RSI to climb past 40 could also hint that momentum is turning.

Injective Gains Strength From Chainlink Integration

Injective (INJ) is gaining momentum as Chainlink goes live on its Mainnet. With EVM deployment, iBuild AI, and on-chain financial modules, INJ allows developers to launch dApps faster than most platforms. Real-time Chainlink Data Streams with sub-second latency now power Injective’s finance-focused blockchain ecosystem.

Helix Markets will be the first dApp on Injective to use these data streams for crypto and RWA markets. Developers benefit from low-latency market data, institutional-grade reliability through ICE Markets and FTSE Russell, and fully customizable formats. Injective’s growing infrastructure and speed make it a strong contender in decentralized finance and market innovation.

Also Read: Injective (INJ) Set for Explosive Rally: Price Could Soar Toward $33!